These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 24507010)

  • 21. Phenotypic variability in Waardenburg syndrome resulting from a 22q12.3-q13.1 microdeletion involving SOX10.
    Jelena B; Christina L; Eric V; Fabiola QR
    Am J Med Genet A; 2014 Jun; 164A(6):1512-9. PubMed ID: 24715709
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of a Novel De Novo Heterozygous Deletion in the SOX10 Gene in Waardenburg Syndrome Type II Using Next-Generation Sequencing.
    Li H; Jin P; Hao Q; Zhu W; Chen X; Wang P
    Genet Test Mol Biomarkers; 2017 Nov; 21(11):681-685. PubMed ID: 29045167
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Phenotypic similarities in pigs with SOX10
    Lin T; Luo L; Guo W; Ren W; Liu C; Wei H; Yang S; Wang Y
    J Genet Genomics; 2020 Dec; 47(12):770-780. PubMed ID: 33766494
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Waardenburg syndrome: a rare cause of inherited neuropathy due to SOX10 mutation.
    Bogdanova-Mihaylova P; Alexander MD; Murphy RPJ; Murphy SM
    J Peripher Nerv Syst; 2017 Sep; 22(3):219-223. PubMed ID: 28544110
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Establishment of an iPSC line (CPGHi005-A) from a patient with Waardenburg syndrome carrying a heterozygous SVA-F retrotransposon insertion into SOX10.
    Li X; Gao X; Huang S; Han M; Kang D; Yang J; Wu X; Zheng Q; Yuan Y; Dai P; Wang G
    Stem Cell Res; 2022 Jul; 62():102831. PubMed ID: 35691110
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Biallelic deletions of the Waardenburg II syndrome gene, SOX10, cause a recognizable arthrogryposis syndrome.
    Stevenson RE; Vincent V; Spellicy CJ; Friez MJ; Chaubey A
    Am J Med Genet A; 2018 Sep; 176(9):1968-1971. PubMed ID: 30113773
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Mutation analysis of seven patients with Waardenburg syndrome].
    Hao Z; Zhou Y; Li P; Zhang Q; Li J; Wang P; Li X; Feng Y
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2016 Jun; 33(3):312-5. PubMed ID: 27264810
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Disease-causing enhancer variants: a question of penetrance.
    Ottolenghi S
    Hum Mutat; 2014 Mar; 35(3):v. PubMed ID: 24532487
    [No Abstract]   [Full Text] [Related]  

  • 29. First Report of Prenatal Ascertainment of a Fetus With Homozygous Loss of the SOX10 Gene and Phenotypic Correlation by Autopsy Examination.
    LeBel DP; Wolff DJ; Batalis NI; Ellingham T; Matics N; Patwardhan SC; Znoyko IY; Schandl CA
    Pediatr Dev Pathol; 2018; 21(6):561-567. PubMed ID: 29216801
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 22q12.3-q13.1 microdeletion including
    Zhang W; Xiao L; Chen B; Xu Y; Yan N
    Eur J Ophthalmol; 2021 Jul; 31(4):2127-2134. PubMed ID: 32703023
    [TBL] [Abstract][Full Text] [Related]  

  • 31. SOX10 mutation in Waardenburg syndrome type II.
    Iso M; Fukami M; Horikawa R; Azuma N; Kawashiro N; Ogata T
    Am J Med Genet A; 2008 Aug; 146A(16):2162-3. PubMed ID: 18627047
    [No Abstract]   [Full Text] [Related]  

  • 32. Can Waardenburg syndrome type 2 be explained by epigenetic mosaicism?
    Happle R
    Am J Med Genet A; 2021 Apr; 185(4):1304-1306. PubMed ID: 33438357
    [No Abstract]   [Full Text] [Related]  

  • 33. A patient with peripheral demyelinating neuropathy, central dysmyelinating leukodystrophy, Waardenburg syndrome, and severe hypoganglionosis associated with a novel SOX10 mutation.
    Akutsu Y; Shirai K; Takei A; Goto Y; Aoyama T; Watanabe A; Imamura M; Enokizono T; Ohto T; Hori T; Suzuki K; Hayashi M; Masumoto K; Inoue K
    Am J Med Genet A; 2018 May; 176(5):1195-1199. PubMed ID: 29681101
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A novel dominant mutation in the SOX10 gene in a Chinese family with Waardenburg syndrome type II.
    Ma J; Zhang Z; Jiang HC; Sun H; Ming C; Zhao LP; Gao YQ; Li ZC; Sun MH; Xiao Y; Wu GL; Zhang TS; Ruan B
    Mol Med Rep; 2019 Mar; 19(3):1775-1780. PubMed ID: 30628718
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A de novo missense mutation in the gene encoding the SOX10 transcription factor in a Spanish sporadic case of Waardenburg syndrome type IV.
    Morín M; Viñuela A; Rivera T; Villamar M; Moreno-Pelayo MA; Moreno F; del Castillo I
    Am J Med Genet A; 2008 Apr; 146A(8):1032-7. PubMed ID: 18348274
    [No Abstract]   [Full Text] [Related]  

  • 36. 22q11.2q13 duplication including SOX10 causes sex-reversal and peripheral demyelinating neuropathy, central dysmyelinating leukodystrophy, Waardenburg syndrome, and Hirschsprung disease.
    Falah N; Posey JE; Thorson W; Benke P; Tekin M; Tarshish B; Lupski JR; Harel T
    Am J Med Genet A; 2017 Apr; 173(4):1066-1070. PubMed ID: 28328136
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Analysis of genetic variation in patients with Waardenburg syndrome type Ⅱ by next generation sequencing].
    Ren SM; Kong XD; Wu QH; Jiao ZH; Chen C; Qin ZB
    Zhonghua Yi Xue Za Zhi; 2020 Mar; 100(11):853-858. PubMed ID: 32234158
    [No Abstract]   [Full Text] [Related]  

  • 38. Establishment of an iPSC line (JTUi002-A) from a patient with Waardenburg syndrome caused by a SOX10 mutation and carrying a GJB2 mutation.
    Wang P; Wang J; Xing Y; Wang H; Yu D; Feng Y; Wu H; Wu Y; Chen Z; Wang J; Shi H
    Stem Cell Res; 2020 Apr; 44():101756. PubMed ID: 32199281
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Genetic and phenotypic heterogeneity in two novel cases of Waardenburg syndrome type IV.
    Viñuela A; Morín M; Villamar M; Morera C; Lavilla MJ; Cavallé L; Moreno-Pelayo MA; Moreno F; del Castillo I
    Am J Med Genet A; 2009 Oct; 149A(10):2296-302. PubMed ID: 19764030
    [No Abstract]   [Full Text] [Related]  

  • 40. Generation of an iPSC line (IMAGINi022-A) from a patient carrying a SOX10 missense mutation and presenting with deafness, depigmentation and progressive neurological impairment.
    Banal C; Quelennec E; Bertani-Torres W; Gacem N; Amiel J; Marlin S; Petit F; Pingault V; Lefort N; Bondurand N
    Stem Cell Res; 2020 Oct; 48():101936. PubMed ID: 32795927
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.